Recommended Topic Related To:

Faslodex

"The U.S. Food and Drug Administration today approved Kadcyla (ado-trastuzumab emtansine), a new therapy for patients with HER2-positive, late-stage (metastatic) breast cancer.

HER2 is a protein involved in normal cell growth. It is foun"...

Faslodex

Faslodex Patient Information including How Should I Take

What should I discuss with my healthcare provider before I receive fulvestrant (Faslodex)?

You should not receive this medication if you are allergic to fulvestrant, or if you are pregnant.

If you have any of these other conditions, you may need a dose adjustment or special tests to safely receive this medication:

  • liver disease;
  • a bleeding or blood clotting disorder; or
  • thrombocytopenia (a low level of platelets in the blood).

FDA pregnancy category D. Fulvestrant can cause harm to an unborn baby or cause birth defects. Do not receive fulvestrant without telling your doctor if you are pregnant. Use an effective form of birth control, and tell your doctor if you become pregnant during treatment.

It is not known whether fulvestrant passes into breast milk or if it could harm a nursing baby. Do not receive this medication without telling your doctor if you are breast-feeding a baby.

How is fulvestrant given (Faslodex)?

Fulvestrant is given as an injection into a muscle of your buttock. Your doctor, nurse, or other healthcare provider will give you this injection.

Fulvestrant is usually given once a month. Do not miss any scheduled appointments.

Side Effects Centers
A A A

Faslodex - User Reviews

Faslodex User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Faslodex sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Breast Cancer

Find support and advances in treatment.